Depreciation Amortization - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GlaxoSmithKline PLC
Depreciation & Amortization Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Depreciation & Amortization
ÂŁ2.9B
CAGR 3-Years
-3%
CAGR 5-Years
-1%
CAGR 10-Years
18%
A
AstraZeneca PLC
NASDAQ:AZN
Depreciation & Amortization
$5.1B
CAGR 3-Years
18%
CAGR 5-Years
6%
CAGR 10-Years
2%
Indivior PLC
LSE:INDV
Depreciation & Amortization
$50m
CAGR 3-Years
28%
CAGR 5-Years
2%
CAGR 10-Years
6%
Hikma Pharmaceuticals PLC
LSE:HIK
Depreciation & Amortization
$219m
CAGR 3-Years
31%
CAGR 5-Years
15%
CAGR 10-Years
12%
Allergy Therapeutics PLC
LSE:AGY
Depreciation & Amortization
ÂŁ4.2m
CAGR 3-Years
2%
CAGR 5-Years
17%
CAGR 10-Years
13%
Dechra Pharmaceuticals PLC
LSE:DPH
Depreciation & Amortization
ÂŁ89.7m
CAGR 3-Years
85%
CAGR 5-Years
65%
CAGR 10-Years
15%

See Also

What is GlaxoSmithKline PLC's Depreciation & Amortization?
Depreciation & Amortization
2.9B GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Depreciation & Amortization amounts to 2.9B GBP.

What is GlaxoSmithKline PLC's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
18%

Over the last year, the Depreciation & Amortization growth was 43%. The average annual Depreciation & Amortization growth rates for GlaxoSmithKline PLC have been -3% over the past three years , -1% over the past five years , and 18% over the past ten years .

Back to Top